ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 26.8 USD -1.69% Market Closed
Market Cap: 4.5B USD

Intrinsic Value

The intrinsic value of one ACAD stock under the Base Case scenario is 23.06 USD. Compared to the current market price of 26.8 USD, ACADIA Pharmaceuticals Inc is Overvalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACAD Intrinsic Value
23.06 USD
Overvaluation 14%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ACADIA Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ACAD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ACAD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ACADIA Pharmaceuticals Inc.

Explain Valuation
Compare ACAD to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ACAD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ACADIA Pharmaceuticals Inc

Current Assets 1.1B
Cash & Short-Term Investments 847m
Receivables 139.4m
Other Current Assets 90m
Non-Current Assets 254.3m
PP&E 53.4m
Intangibles 111.6m
Other Non-Current Assets 89.4m
Current Liabilities 356.6m
Accounts Payable 21.7m
Accrued Liabilities 334.8m
Non-Current Liabilities 56.9m
Other Non-Current Liabilities 56.9m
Efficiency

Free Cash Flow Analysis
ACADIA Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ACADIA Pharmaceuticals Inc

Revenue
1B USD
Cost of Revenue
-84.6m USD
Gross Profit
962.5m USD
Operating Expenses
-721.6m USD
Operating Income
240.9m USD
Other Expenses
20.3m USD
Net Income
261.2m USD
Fundamental Scores

ACAD Profitability Score
Profitability Due Diligence

ACADIA Pharmaceuticals Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional ROE
ROIC is Increasing
Exceptional Gross Margin
63/100
Profitability
Score

ACADIA Pharmaceuticals Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

ACAD Solvency Score
Solvency Due Diligence

ACADIA Pharmaceuticals Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
74/100
Solvency
Score

ACADIA Pharmaceuticals Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc

Wall Street analysts forecast ACAD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACAD is 29.85 USD with a low forecast of 17.17 USD and a high forecast of 40.95 USD.

Lowest
Price Target
17.17 USD
36% Downside
Average
Price Target
29.85 USD
11% Upside
Highest
Price Target
40.95 USD
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ACADIA Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ACAD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ACAD Insider Trading
Buy and sell transactions by insiders

ACAD News

Other Videos
What is the Intrinsic Value of one ACAD stock?

The intrinsic value of one ACAD stock under the Base Case scenario is 23.06 USD.

Is ACAD stock undervalued or overvalued?

Compared to the current market price of 26.8 USD, ACADIA Pharmaceuticals Inc is Overvalued by 14%.

Back to Top